BravoVax Secured Support from Hubei Province on Joint Project with Wuhan University
Author:超级管理员 Release time:2021-12-28 15:46:33
Recently the Department of Science and Technology of Hubei Province offered support to the project proposed by Wuhan University and BravoVax on the joint development of a recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP).
As a low-profile innovation-driven leading vaccine company, BravoVax established close connection with colleges and universities, aiming at utilizing its resources and advantages to support the transformation of scientific research achievements in colleges and universities, as well as achieve sustainable development of the projects!
